Answers are grounded in this paper and cite their sources.
Controlled animal study demonstrates STING inhibition with C-176 limits abdominal aortic aneurysm progression in mice, suggesting targeting innate immunity may curb vascular remodeling.
Abdominal aortic aneurysm (AAA) is a vascular condition characterized by chronic inflammation. The stimulator of interferon genes (STING) pathway is known to contribute to various inflammatory diseases; however, its specific role in AAA pathogenesis remains unclear. This study aims to investigate whether STING signaling participates in the inflammatory mechanisms driving AAA formation. AAA was induced in C57BL/6 male mice fed a high-fat diet via continuous angiotensin II (AngII) infusion using osmotic pumps. The mice were assigned to three groups: Control (saline), AngII + (AAA induction), and AngII + C-176 + (AngII plus daily administration of the STING inhibitor C-176). After 28 days, aortic tissues were collected and analyzed. Treatment with C-176 significantly alleviated AAA pathology, as evidenced by reduced aneurysm incidence, limited aortic dilation, and preserved elastic fiber structure. Although mortality showed a numerical decrease in the treatment group, this difference did not reach statistical significance. Moreover, C-176 downregulated the expression of STING, p-STING, p-TBK-1, and p-IRF-3 in aortic tissues compared to the AngII + group. It also markedly decreased macrophage infiltration and lowered the M1/M2 macrophage ratio. Immunofluorescence analysis confirmed STING colocalization with M1 macrophages within AAA lesions. The cGAS-STING signaling pathway contributes to AAA pathogenesis, partly by promoting pro-inflammatory M1 macrophage polarization.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: